Off-label uses broaden as derms explore Botox

Washington - The number of potential dermatologic uses for botulinum toxin type A (Botox Cosmetic) continues to increase, but the already sizable list probably only represents the tip of the iceberg, says Seth L. Matarasso, M.D., at the annual meeting of the American Academy of Dermatology

Related Videos
Related Content

Lebrikizumab Demonstrates Promising Results in Atopic Dermatitis

March 24th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Highlights from AAD 2023

March 23rd 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

New Technology Could Allow Us to Rethink Alopecia Scores

March 23rd 2023

Upadacitinib Advances to Phase 3 Clinical Trials in Systemic Lupus Erythematosus

March 23rd 2023

Lebrikizumab Demonstrates Promising Results in Atopic Dermatitis

March 24th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Highlights from AAD 2023

March 23rd 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

New Technology Could Allow Us to Rethink Alopecia Scores

March 23rd 2023

Upadacitinib Advances to Phase 3 Clinical Trials in Systemic Lupus Erythematosus

March 23rd 2023

Lebrikizumab Demonstrates Promising Results in Atopic Dermatitis

March 24th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Highlights from AAD 2023

March 23rd 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

New Technology Could Allow Us to Rethink Alopecia Scores

March 23rd 2023

Upadacitinib Advances to Phase 3 Clinical Trials in Systemic Lupus Erythematosus

March 23rd 2023
© 2023 MJH Life Sciences

All rights reserved.